From BODE to ADO to outcomes in multimorbid COPD patients
2009; Elsevier BV; Volume: 374; Issue: 9691 Linguagem: Inglês
10.1016/s0140-6736(09)61539-7
ISSN1474-547X
Autores Tópico(s)Nursing Diagnosis and Documentation
ResumoThe resources spent on research and treatment into chronic obstructive pulmonary disease (COPD) seem ludicrous compared with what could be achieved by simple and better legislation. In fact, the world needs to ban tobacco. Unfortunately, partly because many policy makers have failed to act appropriately, reality is different. COPD remains a major public health concern and is high on the priority list of major organisations, such as WHO. 1 WHO2008–2013 action plan for the global strategy for the prevention and control of non communicable diseases: prevent and control cardiovascular diseases, cancers, chronic respiratory diseases, diabetes. http://www.who.int/nmh/publications/ncd_action_plan_en.pdfDate: 2008 Google Scholar COPD—more than just tobacco smokeOn Sept 12–16, Vienna hosts the European Respiratory Society's annual congress, the largest in pulmonary medicine in the world. As a prelude to the meeting, The Lancet today is devoted to chronic obstructive pulmonary disease (COPD). WHO estimates that 210 million people have COPD worldwide. This number could be higher because many people with COPD often do not seek medical help until the disease worsens. COPD is now an umbrella term to cover emphysema and chronic bronchitis, among others, all of which used to be considered separate conditions. Full-Text PDF Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO indexBoth the updated BODE and ADO indices could lend support to the prognostic assessment of patients with COPD in specialised and primary-care settings. Such assessment enhances the targeting of treatments to individual patients. Full-Text PDF
Referência(s)